Episode 5: Will COVID-19 Change What Is Considered Appropriate Use in Cardiology?

Every day, cardiologists make decisions about what is the most appropriate test, therapy, or procedure for their patients. But then COVID-19 came along. Have the rules of the game changed?

In this episode, NCH Senior Medical Director of Cardiology Dr. Fernando Villacian discusses this important topic with two cardiologists who are not only treating individuals, but also reviewing clinical guidelines in response to COVID-19 and developing new policies in their hospitals: Dr. Nihar Desai, Associate Professor of Medicine and Associate Chief of the Section of Cardiovascular Medicine at Yale University School of Medicine and Medical Director for Value Innovation at the Yale New Haven Health System, and Dr. Ileana Piña, Clinical Professor at Central Michigan University and past chair of the American Heart Association’s Council on Clinical Cardiology.

 

Previous Article
Episode 6: Why Don't More Cardiology Patients Get Optimal Medication Therapy?
Episode 6: Why Don't More Cardiology Patients Get Optimal Medication Therapy?

GDMT, or guideline-directed medical therapy, means taking the right medication at the optimal doses to trea...

Next Article
Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals
Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals

Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.